Stoke Therapeutics (STOK) News Today $13.16 +0.06 (+0.46%) Closing price 04:00 PM EasternExtended Trading$13.02 -0.15 (-1.10%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STOK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth ConferenceAugust 6, 2025 | businesswire.comStoke Therapeutics, Inc. (NASDAQ:STOK) Insider Barry Ticho Sells 4,504 SharesAugust 6, 2025 | marketbeat.comStoke Therapeutics (STOK) Expected to Announce Quarterly Earnings on WednesdayAugust 5, 2025 | americanbankingnews.comThe Oligonucleotide Therapeutics Society Announces the 21st Annual Meeting in Budapest, HungaryAugust 1, 2025 | msn.comStoke Therapeutics (STOK) to Release Quarterly Earnings on WednesdayJuly 30, 2025 | marketbeat.com28,600 Shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) Bought by Dauntless Investment Group LLCJuly 29, 2025 | marketbeat.comStoke Therapeutics Inc. Stock Grades | STOK | Barron'sJuly 28, 2025 | barrons.comStoke Therapeutics, Inc. (NASDAQ:STOK) Given Average Rating of "Buy" by AnalystsJuly 25, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Shares Up 18.1% - Here's WhyJuly 22, 2025 | marketbeat.comKennondale Capital Management LLC Acquires Shares of 42,100 Stoke Therapeutics, Inc. (NASDAQ:STOK)July 22, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Down 4.3% - Here's WhyJuly 21, 2025 | marketbeat.comJefferies Initiates Coverage of Stoke Therapeutics (STOK) with Buy RecommendationJuly 19, 2025 | msn.comJefferies starts Stoke at Buy, sees $1 bln+ opportunity in rare epilepsy drugJuly 19, 2025 | finance.yahoo.comStoke Therapeutics (NASDAQ:STOK) Shares Gap Up - What's Next?July 18, 2025 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Now Covered by Analysts at Jefferies Financial GroupJuly 18, 2025 | marketbeat.comEpilepsy Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 15, 2025 | theglobeandmail.comStoke Therapeutics (NASDAQ:STOK) investors are sitting on a loss of 58% if they invested five years agoJuly 15, 2025 | finance.yahoo.comThe charming Stoke-on-Trent four-bed family home that's 'ready to be lived in'July 13, 2025 | msn.comNew Royal Stoke technology cuts hospital stays by over a dayJuly 13, 2025 | msn.comGrit bin raiders and double parking hinders work to keep Stoke-on-Trent moving in winterJuly 13, 2025 | msn.comFive of the best beer gardens around Stoke-on-Trent to enjoy in the sunJuly 13, 2025 | msn.comMan City prospect told to gain notoriety at Stoke CityJuly 13, 2025 | msn.comLille rival Aston Villa in race for Stoke’s Sol SidibéJuly 10, 2025 | sports.yahoo.comAston Villa want Stoke City midfielder Sol SidibeJuly 10, 2025 | sports.yahoo.comCouncil still against Stoke-on-Trent 'merger' as devolution decision gets nearerJuly 10, 2025 | msn.comStoke City close in on fourth summer signingJuly 10, 2025 | msn.comStoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) CongressJuly 10, 2025 | businesswire.comBiogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) CongressJuly 10, 2025 | globenewswire.comPolice helicopter tracks 4 masked kids on stolen motorbikes in Stoke-on-Trent parkJuly 8, 2025 | msn.comStoke-on-Trent firm collapses into administrationJuly 8, 2025 | msn.comDriver dies in Royal Stoke after hitting treeJuly 8, 2025 | msn.comStoke City move early for 'lethal' rising Manchester City star in second signing of the dayJuly 7, 2025 | msn.comNew Hanford waste incinerator could keep patients warm at Royal StokeJuly 7, 2025 | msn.comStoke sign Talovierov and Man City's MubamaJuly 7, 2025 | msn.comZebra crossings to be installed outside TWO schools on same Stoke-on-Trent roadJuly 5, 2025 | msn.comStoke-on-Trent-based Prohire Limited falls into administrationJuly 5, 2025 | bbc.co.ukMaksym Talovierov makes 'cold nights' promise with brilliant Stoke City statementJuly 5, 2025 | msn.comFive Guys to open first Stoke-on-Trent restaurantJuly 5, 2025 | msn.comMubama set for Stoke loan switchJuly 5, 2025 | sports.yahoo.comPorch pirates target Stoke-on-Trent as parcels swiped from doorstepsJuly 3, 2025 | uk.news.yahoo.comStoke City on brink of agreement for Plymouth Argyle record signingJuly 2, 2025 | msn.comStockley named Stoke's new academy managerJuly 2, 2025 | msn.comStoke Therapeutics' (STOK) "Buy" Rating Reaffirmed at Needham & Company LLCJuly 1, 2025 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Buy" from AnalystsJune 30, 2025 | marketbeat.comSTOK Stoke Therapeutics, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comAnalysts Are Bullish on These Healthcare Stocks: Apogee Therapeutics (APGE), Legend Biotech (LEGN)June 28, 2025 | theglobeandmail.comStoke-on-Trent bungalow could be turned into children's homeJune 28, 2025 | msn.comStoke City confirm new coach appointment as pre-season startsJune 27, 2025 | msn.comStoke Therapeutics (NASDAQ:STOK) Trading Down 3.5% - Here's WhyJune 26, 2025 | marketbeat.comStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | businesswire.com Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address STOK Media Mentions By Week STOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STOK News Sentiment▼0.390.47▲Average Medical News Sentiment STOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STOK Articles This Week▼45▲STOK Articles Average Week Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KYMR News RARE News IMVT News ALVO News CRNX News MIRM News CPRX News OGN News AMRX News NAMS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STOK) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access